Teva, Crohn's disease and Sanofi
As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...
The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.
Sanofi ( (SNY) ) has issued an announcement.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...
Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to ...
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
Sanofi and Regeneron are in the process of testing out blockbuster biologic Dupixent in the indication, for one, and ...
Sanofi has filed a lawsuit against the Biden administration over payment terms in a federal drug discount program.
It's a special delivery for Pocono Services for Families and Children at the Mountain Center in Tobyhanna. Bag after bag of ...
Jean-Paul Kress to join Sanofi's Board of DirectorsParis, December 19, 2024. Sanofi's Board of Directors is pleased to welcome Jean-Paul Kress as ...
The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...
Sanofi announced in early December the inauguration of its state-of-the-art manufacturing facility, Modulus, in Singapore.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback